France · Source-listed medicine information

France / CIS 67786749

PREVENAR 13 suspension injectable. Vaccin pneumococcique polyosidique conjugué (13-valent, adsorbé)

suspension injectable · intramusculaire

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsuspension injectable
Routeintramusculaire
Ingredient entries13
CountryFrance

Product identity

At a glance

Authorisation holder
PFIZER EUROPE MA EEIG (BELGIQUE)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 67786749

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for PREVENAR 13 suspension injectable. Vaccin pneumococcique polyosidique conjugué (13-valent, adsorbé)
IngredientStrength / referenceSource role
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 19F CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 12
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 3 CONJUGUÉ À LA PROTÉINE VECTRICE CRM 197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 2
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 6A CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 5
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 14 CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 9
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 9V CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 8
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 4 CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 3
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 1 CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 1
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 6B CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension4,4 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 6
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 19A CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 11
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 23F CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 13
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 7F CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 7
OLIGOSIDE PNEUMOCOCCIQUE SÉROTYPE 18C CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 10
POLYOSIDE PNEUMOCOCCIQUE SÉROTYPE 5 CONJUGUÉ À LA PROTÉINE VECTRICE CRM197suspension2,2 microgrammes de polyoside pneumococciqueune dose (0,5 ml)SAGroup 4

Pack references

Presentations (1)

1 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s)

CIP13 3400939901152

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 67786749 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →